Cumberland Pharmaceuticals Inc. (CPIX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 59.53M |
| Enterprise Value | 58.26M |
| P/E Ratio | -11.27 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 1.99 |
| Price/Book Ratio | 3.85 |
| Enterprise/Revenue | 1.97 |
| Enterprise/EBITDA | -45.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.17 |
| Operating Margin | -0.17 |
| Return On Assets | -0.1 |
| Return On Equity | -0.29 |
| Revenue | 44.52M |
| Revenue/Share | 2.8 |
| Gross Profit | 37.85M |
| EBITDA | 2.96M |
| Net Income | -2.84M |
| Diluted EPS | -0.19 |
| Total Cash | 11.01M |
| Total Cash/Share | 0.74 |
| Total Debt | 10.07M |
| Total Debt/Equity | 0.47 |
| Current Ratio | 0.95 |
| Book Value Per Share | 1.42 |
| 52-Week Change | 41.73 |
| 52-Week High | 6.61 |
| 52-Week Low | 1.85 |
| Moving Average 50 Days | 4.76 |
| Moving Average 200 Days | 3.72 |
| Average Volume | 981,095 |
| Shares Outstanding | 14.98M |
| % Held by Institutions | 18.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |